## Run Notes

- Workflow executed per `.agents/skills/biomedical-investigation/SKILL.md`.
- Stage order completed as requested: plan -> evidence -> report.
- Structured/curated sources used where available:
  - NCBI PubMed E-utilities (esearch/efetch) for literature identifiers.
  - UniProt REST for target identity (`UniProt:Q5S007`).
  - ClinicalTrials.gov API v2 for interventional trial status (`NCT05418673`, `NCT05348785`, `NCT06602193`).
  - ChEMBL and PubChem REST for tractability/compound identifiers (`CHEMBL2010622`, `CHEMBL4098877`, `PubChem:CID:78319901`).
- Source identifiers were preserved in `evidence.jsonl`, `claims.jsonl`, and `report.md`.
- No existing artifacts were overwritten outside `.co-scientist/investigations/lrrk2-parkinsons/`.
- Follow-up edit completed: comparison table kept in `report.md`; process notes remain here instead of the user-facing report.
- Artifact repair completed after review: plan status and step statuses now match the completed bundle, tool hints use stable identifiers, expression evidence was added from GTEx/HPA, and chemistry evidence was expanded with concrete assay details.
- Follow-up suggested: enrich with trial publication outcomes and genotype-stratified biomarker response extraction.
